Tamtam Try Tamtam free
Centene Corporation logo

Centene Corporation account plan

Local integrated healthcare plans

At a glance

Centene is a St. Louis managed care company focused on underserved populations, with $194.8 billion of 2025 revenue and 25.9 million members in June 2026.

Centene, headquartered in St. Louis and listed on the NYSE as CNC, runs government-sponsored and commercial health plans through state-based subsidiaries with local brands. It is the largest Medicaid and Marketplace insurer and the largest stand-alone Medicare prescription drug plan provider in the U.S. In FY2025 total revenues were $194.8 billion (+19%), but a $6.7 billion non-cash goodwill impairment led to a net loss attributable to Centene of $(6,674) million; adjusted diluted EPS was $2.08. Membership was 27.6 million at December 31, 2025, served by approximately 61,100 team members.

Business units

Strategic priorities

Margin restoration
Corrective 2026 Marketplace pricing in states covering 95% of membership, Medicaid rates matched to post-redetermination acuity, and medical cost management including fraud, waste and abuse detection.
Dual-eligible integration
Centene will "place enterprise-level focus on the D-SNP opportunity to drive long-term growth"; D-SNP members are about 40% of Medicare Advantage, and new integrated duals contracts began in Illinois, Ohio and Michigan in January 2026.
Industry-leading cost structure
Enterprise optimization simplifies the organisation and operating model through digitisation, AI and voluntary buyouts, with an estimated $480 million midpoint of related SG&A costs in 2026.
AI on trusted data foundations
AI work is shifting from use cases to trusted data products, context management and open standards under a strict ROI bar, and finance uses analytics and AI in forecasting, medical economics and payment integrity.
ICHRA and value-based care
ICHRA plans expanded from 6 to 13 states in 2026 and reached roughly 50,000 members, and providers are being moved toward shared and full risk arrangements.

Latest results

In Q2 2026 total revenues rose 10% to $53.6 billion and premium and service revenues 4% to $44.4 billion. The health benefits ratio improved to 89.6% from 93.0%, helped by better Marketplace pricing and risk adjustment, Medicaid rate increases and cost management; GAAP diluted EPS was $2.19 and adjusted diluted EPS $2.51. Membership fell 8% year on year to 25.9 million, mainly in the Marketplace. Full-year 2026 adjusted EPS guidance was raised to greater than $4.80 from greater than $3.40, though about $0.50 of Q2 earnings came from 2025 settlements not expected to recur in 2027.

Investments and deals

Systems capex
Capex was $767 million in 2025; about $800 million is expected in 2026, mainly system enhancements and computer hardware and software.
Deleveraging
$1.3 billion of senior notes were repurchased in H1 2026, partly funded by selling a $1.0 billion interest in 2025 Part D receivables; debt-to-capital fell to 41.6% from 46.5%.
Magellan Health divestiture
A definitive agreement to divest the remaining Magellan Health businesses was signed in December 2025, after a $513 million impairment.
Voluntary separation program
Accepted on July 27, 2026, with about $315 million to $365 million of severance expected over the rest of 2026.

Challenges and risks

Medicaid policy changes
The One Big Beautiful Bill Act brings Medicaid work requirements and more frequent redeterminations largely from 2027; Medicaid membership is expected down 8% to 9% in 2026.
Marketplace membership and morbidity
Expiry of enhanced Marketplace subsidies at end-2025 cut membership from 5,541,400 to 3,494,700 by June 2026 and raised the acuity of remaining members.
Medical cost trend
Behavioral health remains the largest trend driver, with home health and high-cost drugs, and payment-integrity teams target "AI up-coding".
Contract losses
Centene was not selected for Florida Children's Medical Services, its Hawaii Medicaid contracts were not renewed, and about 250,000 California Medi-Cal members leave managed care on January 1, 2027.

What leadership says

“delivering industry-leading health outcomes with an industry-leading cost structure.”

Sarah London, Chief Executive Officer · Q2 2026 earnings call, July 29, 2026

“We aren't just going to deploy AI to talk about AI.”

Sarah London, Chief Executive Officer · Q2 2026 earnings call, July 29, 2026

“this work is not about self-regulating, it's about self disrupting.”

Sarah London, Chief Executive Officer · Q1 2026 earnings call, April 28, 2026, on prior authorization commitments

“They saw and called a market-wide issue first.”

Sarah London, Chief Executive Officer · Q2 2026 earnings call, July 29, 2026, on the Marketplace team

Where a supplier can help

AI with measurable ROI
Centene is building trusted data products and holds AI to a strict ROI bar; vendors with proven savings in claims, legal or administrative work fit the enterprise optimization priority.
Payment integrity and fraud detection
Medical cost management relies on catching inappropriate billing before payment, including AI up-coding, which suits payment-integrity and analytics providers.
Eligibility and work-requirement support
OBBBA work requirements and redeterminations push Centene to exchange near real-time data with states and run workforce playbooks, where eligibility, data exchange and community engagement partners can help.
Dual-eligible care programmes
The D-SNP focus calls for care coordination, member engagement and value-based care partners in oncology, kidney disease and behavioral health.
System modernisation
About $800 million of 2026 capex goes to system enhancements and hardware and software, alongside digitisation under enterprise optimization.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Centene Corporation?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Centene Corporation

What does Centene do?

Centene is a managed care company focused on underserved populations. It runs Medicaid, Marketplace (Ambetter Health) and Medicare (Wellcare and stand-alone drug plans) health plans through state-based subsidiaries.

What is Centene's revenue?

Total revenues were $194.8 billion in FY2025, up 19%. In Q2 2026 total revenues were $53.6 billion, up 10%.

How many employees and members does Centene have?

Centene had approximately 61,100 team members and 27.6 million members at December 31, 2025; membership was 25.9 million at June 30, 2026.

What is Centene's strategy?

It is restoring margins through repricing and medical cost management, focusing Medicare on dual-eligible D-SNP members, simplifying the organisation, and growing ICHRA products.

Who leads Centene?

Sarah M. London has been CEO since March 2022, with Andrew L. Asher as EVP and CFO and Susan R. Smith as COO.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)